Skip to content
DataLookout
Menu

NATI-FabNCT07872852

Therapeutic Implications of CMR Low Native T1 in Non-treated Non-hypertrophic Females With Fabry Disease (FD)

StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Proportion of non-treated non-hypertrophic Fabry females for whom the indication for specific Fabry therapy (ERT or chaperone) is modified (i.e. established) based on additional information provided by low native myocardial T1 value.
Timeframe: Month 12

Secondary (4)

Association of low native T1 value with phenotype
Association of low native T1 value with genotype
Association of low native T1 value with cardiac status
Disease progression

Arms and interventions

CMR low native myocardial T1 valueExperimental

Potential therapeutic impact of CMR myocardial native T1

Other: Decision tree for initiating treatment

Sites

12 sites in 1 country